261 related articles for article (PubMed ID: 22000695)
1. Small-cell lung cancer: prognostic factors and changing treatment over 15 years.
Gaspar LE; McNamara EJ; Gay EG; Putnam JB; Crawford J; Herbst RS; Bonner JA
Clin Lung Cancer; 2012 Mar; 13(2):115-22. PubMed ID: 22000695
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with small cell lung carcinoma in Taiwan.
Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
[TBL] [Abstract][Full Text] [Related]
3. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
4. Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base.
Gaspar LE; Gay EG; Crawford J; Putnam JB; Herbst RS; Bonner JA
Clin Lung Cancer; 2005 May; 6(6):355-60. PubMed ID: 15943896
[TBL] [Abstract][Full Text] [Related]
5. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
[TBL] [Abstract][Full Text] [Related]
6. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
Patel S; Macdonald OK; Suntharalingam M
Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
Schreiber D; Rineer J; Weedon J; Vongtama D; Wortham A; Kim A; Han P; Choi K; Rotman M
Cancer; 2010 Mar; 116(5):1350-7. PubMed ID: 20082453
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy.
Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647
[TBL] [Abstract][Full Text] [Related]
11. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database.
Lally BE; Geiger AM; Urbanic JJ; Butler JM; Wentworth S; Perry MC; Wilson LD; Horton JK; Detterbeck FC; Miller AA; Thomas CR; Blackstock AW
Lung Cancer; 2009 May; 64(2):226-31. PubMed ID: 18835059
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
13. Prognostic analysis of limited-stage small cell lung cancer after chemoradiotherapy.
Su J; Zhu S; Liu Z; Jing S; Shen W; Li J
Onkologie; 2012; 35(6):362-7. PubMed ID: 22722457
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
15. A 20-year retrospective study of small-cell carcinomas in Taiwan.
Li AF; Hsu HS; Hsu CY; Li AC; Li WY; Liang WY; Chen JY
J Surg Oncol; 2010 Oct; 102(5):497-502. PubMed ID: 20872953
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
[TBL] [Abstract][Full Text] [Related]
17. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
[TBL] [Abstract][Full Text] [Related]
18. Lobectomy leads to optimal survival in early-stage small cell lung cancer: a retrospective analysis.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; DeCamp MM
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):538-46. PubMed ID: 21684554
[TBL] [Abstract][Full Text] [Related]
19. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]